Nerve-Repair and Regeneration Market and its Growth Prospect in the Near Future
The nerve repair and regeneration market is expected to reach $14.9 billion by 2023, growing at a CAGR of 11.9% between 2017-2023.
By: P&S Intelligence
Request to Get the Sample Pages at:
As per the findings of the research, the market for neurostimulation and neuromodulation devices was larger than the market for biomaterials. Internal devices form the larger part of the neurostimulation and neuromodulation devices market. Within internal neurostimulation and neuromodulation devices, spinal cord stimulation devices generate the largest revenue in the market. In terms of application, neurostimulation and neuromodulation surgeries has been the largest application area of the nerve repair and regeneration market (https://www.psmarketresearch.com/
The nerve repair and regeneration market is highly consolidated with top three players including Medtronic, Plc, Boston Scientific Corporation and St. Jude Medical, Inc. holding the major share. Medtronic Plc dominated the market in 2016. The company offers implantable neurostimulation and targeted drug delivery systems, such as SCS, DBS, GES and SNS systems for the management of chronic pain, common movement disorders, spasticity and urologic and gastrointestinal disorders.
Some of the other key players in the nerve repair and regeneration market are Axogen, Inc., Baxter International Inc., Cyberonics, Inc., Integra Lifesciences Holdings Corporation, Orthomed S.A.S., Stryker Corporation and Polyganics B.V.